N/A
Average AnalystN/A
Top AnalystNeutral
Stock Target AdvisorN/A
Average UserEUR 27.20
-2.60 (-8.72)%
EUR 2.45B
13.00
EUR -1.00
Based on the PTC Therapeutics Inc. stock forecast from 0 analysts, the average analyst target price for PTC Therapeutics Inc. is not available over the next 12 months. PTC Therapeutics Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of PTC Therapeutics Inc. is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, PTC Therapeutics Inc.’s stock price was EUR 27.20. PTC Therapeutics Inc.’s stock price has changed by -14.47% over the past week, -4.23% over the past month and -25.68% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had negative total free cash flow in the most recent four quarters.